Hudson Valley iCampus, New York’s premier research and innovation hub in the Hudson Valley, is proud to announce that they have closed lease and renewal deals totaling 337,589 square feet on campus, with a value of more than $40 million. The transactions took place between August 2021 and December 2022.
“We are very pleased with how swiftly our rebranding program and outreach to the community has positively impacted our leasing efforts,” said Jamie Schwartz, President of Hudson Valley iCampus. “Additionally, the strong onsite management team we have built enables us to provide our tenants with best-in-class management, which continues well after a lease is signed.”
Improvements can be seen throughout the 207-acre campus — from signage and infrastructure to roadways and security.
“The campus is quickly becoming the premier address in the New York tri-state region. We’re excited to take this momentum into 2023 and build upon our success in creating a community where innovation, ingenuity and industry can thrive,” said Schwartz.
Some of the key transactions were:
Pfizer, Inc. (NYSE: PFE), an American multinational pharmaceutical and biotechnology corporation, leased a total of 86,243 square feet of office and laboratory space in multiple buildings at the campus. Pfizer also owns approximately 30 adjacent acres housing additional laboratory and office space. Cushman & Wakefield represented Pfizer.
Momentive Performance Materials, Inc. leased 66,430 square feet in a previously vacant building at the campus. Momentive is a global high-performance silicones and specialties company that is relocating from Tarrytown, N.Y. to open a Global Innovation Center to support its growing performance additives business. Andrew Tarvin of Tarvin Commercial Real Estate Services represented Momentive. John Cunningham of JLL represented the landlord.
Urban Electric Power, Inc., a company that is revolutionizing the traditional alkaline battery (e.g., double A) by transforming it into a powerful rechargeable battery, renewed its lease for 36,048 rentable square feet of manufacturing space.
Auro Vaccines, LLC, renewed its 17,500 square feet of laboratory space. Auro Vaccine is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Andrew Tarvin of Tarvin Commercial Real Estate Services represented Auro Vaccines.
Olaplex, Inc. (Nasdaq: OLPX), expanded its footprint and renewed its 4,537 square feet of laboratory and office space. Olaplex is an innovative, science-enabled, technology-driven beauty company. Rob Lella of Colliers represented the landlord.
